| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 08/01/2001 | EP0649434B1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 08/01/2001 | EP0631503B1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 08/01/2001 | EP0569583B1 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 08/01/2001 | CN1306441A Pare-hydrogen labelled agents and their use in magnetic resonance imaging |
| 07/31/2001 | US6268159 Visualizing tumor cells; administer radioactive particles to humans and detect positioning and accumulation of radioactive particles in body |
| 07/31/2001 | CA2237263C Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 07/31/2001 | CA2194294C Complexes for use in the diagnosis of vascular diseases |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001052899A1 Chelating agents and method for their use as tandem metal chelators and hydrophilic spacers for medical diagnosis and therapy |
| 07/26/2001 | WO2001052898A1 Methods for incorporating metal chelators at carboxyl-terminal site of peptides |
| 07/26/2001 | WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 07/26/2001 | WO2001052744A1 Hydrophilic cyanine dyes |
| 07/26/2001 | WO2000061196A3 Fatty acid analogs for diagnosis of coronary artery disease |
| 07/26/2001 | WO2000059547A3 Method of detecting endometriosis |
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses |
| 07/26/2001 | US20010009657 Determining effects of external stimuli on the brain using PET |
| 07/26/2001 | US20010009656 For treating solid mass tumors via catheter delivery, comprising a biocompatible polymer, a biocompatible solvent and a water insoluble radioisotope of given radioactive content |
| 07/26/2001 | CA2397833A1 Novel haptotactic peptides |
| 07/25/2001 | EP1117833A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117355A1 Targeted therapy to a biomedical device |
| 07/25/2001 | EP1117351A2 Drug delivery systems |
| 07/25/2001 | EP0862464A4 Amino acid analogs for tumor imaging |
| 07/25/2001 | EP0642357B1 Radiolabelled somatostatin |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265187 Recombinant endotoxin-neutralizing proteins |
| 07/24/2001 | US6264949 Administering label molecule |
| 07/24/2001 | US6264917 Targeted ultrasound contrast agents |
| 07/24/2001 | US6264914 Contrast agents |
| 07/24/2001 | US6264913 Using carbon labeled sorbitol |
| 07/24/2001 | US6264598 Palladium coated implant |
| 07/24/2001 | US6264597 Having as a radioactive material cu-62 or ta-178; treatment of blood vessel walls during or subsequent to balloon angioplasty to delay or eliminate restenosis |
| 07/24/2001 | US6264596 In-situ radioactive medical device |
| 07/24/2001 | US6264595 Radioactive transition metal stents |
| 07/24/2001 | CA2065299C Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 07/19/2001 | WO2001051091A1 Bioconjugates and uses thereof |
| 07/19/2001 | WO2001005383A3 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 07/19/2001 | WO2000040229A3 Synergistic tumorcidal response induced by histamine |
| 07/19/2001 | US20010008625 Receptor binding conjugates |
| 07/18/2001 | EP1115866A1 Cystine knot growth factor mutants |
| 07/18/2001 | EP1115429A1 Somatostatin receptor radioligand with increased uptake |
| 07/18/2001 | EP1115426A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 07/18/2001 | EP0639083B1 Complexing agents and targeting immunoreagents |
| 07/17/2001 | US6263232 Method and kit for locating hyperactive parathyroid tissue or adenomatious tissue in a patient and for removal of such tissue |
| 07/17/2001 | US6262107 Conjugated to a water soluble polyglutamic acid polymer |
| 07/17/2001 | US6261537 Targets and ultrasound diagnosis of active materials, aqueous carrier liquids, carriers and film forming surfactant phosphatides |
| 07/17/2001 | US6261536 Post labeling stabilization of radiolabeled proteins and peptides |
| 07/17/2001 | US6261535 Images of tumors |
| 07/12/2001 | WO2001049358A1 Medical devices that resist restenosis |
| 07/12/2001 | WO2000078774A3 Induction of pharmacological stress with adenosine receptor agonists |
| 07/12/2001 | US20010007916 Radioactive balloon for balloon dilatation catheter system and process for preparation thereof |
| 07/12/2001 | CA2395672A1 Medical adhesives |
| 07/11/2001 | EP1114046A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303393A Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 07/11/2001 | CN1303289A Adenosine A3 receptor modulators |
| 07/11/2001 | CN1303273A Use of particulate contrast agents in diagnostic imaging for studying physiological parameters |
| 07/11/2001 | CN1302665A Medicine for treating thyroidism accompanied by infiltrative exorbitism |
| 07/11/2001 | CN1068229C Ultrasonic contrast medium, contrast agent containing this medium and method |
| 07/10/2001 | US6258338 Comprising beta-emitting radionuclide of yttria used in internal radiation therapy of cancer and tumors of the liver |
| 07/05/2001 | WO2001047564A2 Labelled ascorbic acid derivatives |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006822 Generating libraries of ligands |
| 07/05/2001 | US20010006619 Compounds for cancer imaging and therapy |
| 07/05/2001 | US20010006618 Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy |
| 07/05/2001 | US20010006616 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 07/05/2001 | US20010005930 Method of making a hollow-tube precursor brachytherapy device |
| 07/05/2001 | CA2394959A1 Labelled ascorbic acid derivatives |
| 07/04/2001 | EP1112086A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells |
| 07/04/2001 | EP1112084A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 07/04/2001 | CN1302211A Improvements in/or relating to diagnostic/therapeutic agent |
| 07/04/2001 | CN1067984C Mercapto-alkyl monosubstituted o-phenylene diamine derivatives, its preparation and radio nuclide compound |
| 07/03/2001 | US6255519 Radiolabelled pharmaceuticals and biological probes ueful in cancer diagnosis and treatment; imaging technology |
| 07/03/2001 | US6255105 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 07/03/2001 | US6254851 Diagnostic agents for pancreatic exocrine function |
| 07/03/2001 | US6254850 Polycarboxyalkylaminoalkanes for complexes |
| 07/03/2001 | US6254552 A wire, a radiation source deposited or absorbed on wire, and a biocompatible material scaling the radiation and wire |
| 07/03/2001 | CA2107466C Low density microspheres and their use as contrast agents for computed tomography |
| 07/03/2001 | CA2012993C Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/28/2001 | WO2001046176A2 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | WO2000076450A3 Recombinant adenoviruses for the sodium/iodide symporter (nis) |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | DE19964224A1 New calcium complex of oxa-diaza-phosphaundecane derivative MS-325, useful as stabilizer for diagnostic compositions containing gadolinium complex of MS-325 and as antidote for heavy metal poisoning |
| 06/28/2001 | CA2399584A1 Non peptide tachykinin receptor antagonists |
| 06/27/2001 | EP1110963A2 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
| 06/27/2001 | EP1109937A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 06/27/2001 | EP1109900A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 06/27/2001 | EP1109795A1 Thiazoline acid derivatives |
| 06/27/2001 | EP1109583A1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement |
| 06/27/2001 | EP1109539A1 Nanogel networks and biological agent composition thereof |
| 06/27/2001 | EP0820473B1 Biodegradable polyacetal polymers and formation and use |
| 06/27/2001 | CN1067591C Multiple elements composite powder able to improve obviously microcirculation of human body |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251903 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist |
| 06/26/2001 | US6251394 Method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 06/26/2001 | US6251364 Ligands with active groups and radioactive materials |
| 06/26/2001 | US6251362 Method of establishing the optimal radiation dose |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044205A2 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |